Retatrutide, a versatile drug, exhibited effective weight loss, musculoskeletal issues, and restlessness in clinical trials. The drug caused considerable decrease in body mass and improved metabolic markers in people with excess weight and metabolic syndrome. The results were published in HCPLive, showing the drug's potential in addressing diverse health concerns.